Skip to main content

Table 2 Serum PSA, Testosterone, and Cholesterol Before and During Study

From: Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy

Pt No.

PSA at entry (ng/ml)

PSA at 12 months (ng/ml)

Free PSA at entry (ng/ml)

Free PSA at 12 months (ng/ml)

Testosterone at entry (ng/ml)

Testosterone at 12 months (ng/ml)

Free Testosterone at entry (ng/ml)

Free Testosterone at 12 months (ng/ml)

Cholesterol at entry (mg/dl)

Cholesterol at 12 months (mg/dl)

1

0.57

1.93

0.10

0.381

493

468

N/A

10.1

195

207

2

0.50

0.35

0.08

0.007

331

382

46.7

8.5

148

134

3

1.76

1.62

N/A

N/A

259

263

11.9

N/A

229

N/A

4

1.17

N/A

0.11

N/A

508

N/A

9.3

N/A

109

N/A

5

6.87

11.23

N/A

1.690

324

299

N/A

5.7

203

173

6

5.94

13.41

0.83

2.250

N/A

418

N/A

9.7

140

134

7

1.18

1.73

N/A

0.280

264

118

N/A

5.5

162

141

8

0.67

N/A

0.08

N/A

264

N/A

10.2

N/A

167

N/A

9

0.15

0.12

0.01

N/A

68

68

3.4

N/A

260

197

10

0.4

N/A

N/A

N/A

360

N/A

N/A

N/A

N/A

N/A

11

18.86

N/A

N/A

N/A

137

N/A

4.6

N/A

199

N/A

12

11.21

N/A

1.49

N/A

204

N/A

N/A

N/A

134

N/A

13

0.74

0.67

0.07

N/A

565

N/A

15.6

N/A

319

N/A

14

3.49

3.90

0.22

3.902

280

265

10.4

9.7

151

145

15

1.36

1.59

N/A

N/A

521

487

19.3

N/A

255

235

16

0.50

0.50

N/A

0.020

N/A

281

N/A

12.0

N/A

200

17

2.67

5.15

0.15

0.290

287

382

9.8

0.9

180

170

18

0.59

1.10

N/A

0.100

333

317

4.0

47.6

147

163

19

1.04

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

20

0.79

1.05

N/A

N/A

299

N/A

10.5

N/A

116

171

Median

1.11

1.61

0.11

0.19

299

308

10.3

9.7

167

171

P value

0.081

0.285

0.064

0.031

0.806

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us